Trials / Completed
CompletedNCT00171613
A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity Patients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 32 (planned)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 6 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
The extension protocol is designed to allow those patients randomized to placebo in the core portion of the protocol to receive a 6 month treatment of open label octreotide and allow those patients randomized to octreotide who appeared to benefit from treatment, to continue to receive octreotide.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Octreotide |
Timeline
- Start date
- 2005-02-01
- Primary completion
- 2005-10-01
- First posted
- 2005-09-15
- Last updated
- 2012-04-30
Source: ClinicalTrials.gov record NCT00171613. Inclusion in this directory is not an endorsement.